BRNS
Barinthus Biotherapeutics plc
NASDAQHealthcareBiotechnologyGB
Rating:B
Company Profile
CEO
William James Enright
IPO Date
2021-04-30
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
GB
Barinthus Biotherapeutics plc
CEO
William James Enright
IPO Date
2021-04-30
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
GB
| 20,174 |
| $1.00 |
| 11 Jun 2025 | Wright Robin | director | A-Award | Acquired | 20,174 | $1.00 |
| 11 Jun 2025 | Morgon Pierre A. | director | A-Award | Acquired | 20,174 | $1.00 |
| 11 Jun 2025 | Phillips Anne M. | director | A-Award | Acquired | 20,174 | $1.00 |
| 11 Jun 2025 | Scheeren Joseph | director | A-Award | Acquired | 20,174 | $1.00 |
| 11 Jun 2025 | DAWES KAREN A | director | A-Award | Acquired | 20,174 | $1.00 |
| 5 Feb 2025 | Enright William | director, officer: Chief Executive Officer | A-Award | Acquired | 600,000 | $1.00 |
| 14 May 2024 | Phillips Anne M. | director | A-Award | Acquired | 19,516 | $2.34 |
| 14 May 2024 | DAWES KAREN A | director | A-Award | Acquired | 19,516 | $2.34 |